Americans exhibit significantly higher trust in science and greater readiness to accept vaccinations compared to citizens in peer nations, despite deep domestic divisions along religious, geographic, and educational lines, according … Read More
Steven Quay, a biopharmaceutical executive and advocate of the COVID-19 lab leak theory, is no longer the leading candidate to direct the National Institute for Allergy and Infectious Diseases, according … Read More
A new Harvard T.H. Chan School of Public Health study published in JAMA reveals that U.S. hospital closures outpaced openings between 2010 and 2025, resulting in a net loss of … Read More
New research published in PLOS One demonstrates that tailoring public health messaging to align with the values of vaccine-hesitant individuals—specifically by acknowledging distrust of government and affirming personal liberty—increases their … Read More
Published in Science Advances, a comprehensive review by Monash University researchers urges coordinated global action—combining vector control, vaccine deployment, and aggressive greenhouse gas reductions—to combat the escalating spread of mosquito-borne … Read More
Merck discontinued Recarbrio, a specialized three-drug antibiotic approved seven years ago to treat severe hospital-acquired infections, from the U.S. market. The abrupt withdrawal of the critical last-resort treatment highlights ongoing … Read More
Smart vaping devices that combine nicotine or cannabis delivery with smartphone apps, artificial intelligence, and cryptocurrency rewards are raising significant public health concerns. Published in a New England Journal of … Read More
The Baltic Sea faces a severe ecological crisis as researchers from Sweden, Finland, Lithuania, and Latvia warn that pharmaceutical pollution is adding intense pressure to an already vulnerable semi-enclosed marine … Read More
Heidi Overton, the presidential nominee to lead the Food and Drug Administration, faced tough questioning from senators in Washington during a two-hour confirmation hearing. Rather than detailing policy plans on … Read More
A shortened 30-day course of benznidazole taken once daily matches the efficacy of standard 60-day treatments for chronic Chagas disease while dramatically reducing adverse side effects, according to findings from … Read More
